Frank M. Sacks
Genetics · 2009
A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 9 researchers here, as inferred from the citation graph.
Subfields
- Genetics — 11 citations into it; #1,509 of 6,854 by trust here, #2,312 by citations
- Cancer Research — 8 citations into it
Whom Frank M. Sacks trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Frank M. Sacks overall
- C. V. Dang
- Craig B. Thompson
- Q. Ostrom
- Chao Lu
- Patrick S. Ward
- Ralph J. Deberardinis
- Michele Ceccarelli
- Michael R. Stratton
- Michael Weller
Papers from Frank M. Sacks's perspective
Ordered by how strongly the researchers Frank M. Sacks trusts endorse each paper. Same corpus, a different order for every researcher.
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme (Science)
- Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. (Cancer Cell)
- Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. (The Lancet)
- IDH1 and IDH2 mutations in gliomas. (New England Journal of Medicine)
- PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. (Journal of the National Cancer Institute)
- MGMT gene silencing and benefit from temozolomide in glioblastoma. (New England Journal of Medicine)
- IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. (American Journal of Pathology)
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α (Science)
- Analysis of the IDH1 codon 132 mutation in brain tumors (Acta Neuropathologica)
- Pathology and genetics of tumours of the nervous system.
Their papers
- IDH1 and IDH2 Mutations in Gliomas (2009) — 3,049 citations